Open an account

Core Laboratories

CLB · NYSE

$10.06−$0.09 (−0.89%)TodayMarket closed ·
Prev close $10.15

About CLB

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company is headquartered in Houston, Texas and currently employs 3,300 full-time employees. The company went IPO on 2018-10-22. The firm helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. The company makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. The company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

Employees
3,300
Headquarters
Houston, Texas
Listed
Oct 22, 2018
Sector
Energy
Industry
Energy Equipment & Services
Website
corelab.com

CLB key statistics

Market cap
461.60M
Price-earnings ratio
19.52
Dividend yield
0.40%
Average volume
673.88K
Volume
376.52K
Open price
$10.24
High today
$10.35
Low today
$9.95
52 Week high
$20.36
52 Week low
$9.48

Core Laboratories (CLB) at a glance

Core Laboratories (CLB) last traded at $10.06, with a market cap of 461.60M, a price-to-earnings ratio of 19.52 and a dividend yield of 0.40%.

Today the stock has traded between $9.95 and $10.35. The current price is 1.1% above the day's low and 2.8% below its high.

Volume so far is 376.52K shares, below the average of 673.88K shares a day.

Over the past year Core Laboratories has ranged from $9.48 to $20.36, and now sits 5% of the way up that range.

Core Laboratories met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.11 per share against an estimate of $0.0879.

CLB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 13.8% on average.

  1. Q3 FY24: reported $0.25 per share against an estimate of $0.2333
  2. Q4 FY24: reported $0.22 per share against an estimate of $0.2206
  3. Q1 FY25: reported $0.14 per share against an estimate of $0.1469
  4. Q2 FY25: reported $0.19 per share against an estimate of $0.1906
  5. Q3 FY25: reported $0.22 per share against an estimate of $0.1949
  6. Q4 FY25: reported $0.21 per share against an estimate of $0.1906
  7. Q1 FY26: reported $0.06 per share against an estimate of $0.1094
  8. Q2 FY26: reported $0.11 per share against an estimate of $0.0879

CLB news

  • Press releasePRNewswire

    CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

  • Press releasePRNewswire

    CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

  • Press releasePRNewswire

    CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

  • Press releasePRNewswire

    Gulfport Energy and Mobility Global Set to Join S&P SmallCap 600

  • Press releasePRNewswire

    CORE LAB REPORTS FIRST QUARTER 2026 RESULTS

  • Press releasePRNewswire

    CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE

  • Press releasePRNewswire

    CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

  • Press releasePRNewswire

    CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.